A Post-Marketing Safety Study using a Pregnancy Registry to Evaluate the Safety of Respiratory Syncytial Virus Vaccine (ABRYSVO™) Exposure During Pregnancy (C3671041) First published 07/06/2024 Last updated 03/06/2025 EU PAS number:EUPAS1000000179 Study Ongoing